Dr. Sterling Myles Dubin, MD

Dr. Dubin practices at Cedars-Sinai Medical Care Foundation in Santa Monica, California.

Dr. Dubin's NPI, 1215223474, was assigned on June 24, 2011. Dr. Dubin graduated from George Washington University School of Medicine and Health Sciences in 2011. Dr. Dubin holds California license A123277.

Dr. Dubin's primary practice is Cedars-Sinai Medical Care Foundation, at 1919 Santa Monica Blvd, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 385-3200.

Dr. Dubin's primary practice is Cedars-Sinai Medical Care Foundation in Santa Monica, California. Dr. Dubin is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Dubin to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dubin practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Dubin's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Dubin is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Dubin is licensed in California.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids and intestinal diverticulosis among the conditions Dr. Dubin treats.

CMS data shows 790 Medicare services from Dr. Dubin across 10 procedure codes in 2024, for 428 Medicare patients. Medicare paid $89,645 for them.

CMS counts 428 Medicare patients who saw Dr. Dubin in 2024. The largest group is 75 to 84, with 187 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dubin's median patient age at 62, with 48% women.

In 2024, Dr. Dubin wrote 812 Medicare Part D claims for 321 patients. 75% of them were for generic drugs. CMS names the drug for 711 of them, across 19 drugs with 11 or more claims each, at $178,273 in total drug cost. In 2023, CMS named 696 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Dubin for performance year 2024, reported as part of a group. Dr. Dubin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dubin as offering telehealth. CMS counts 102 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Dubin, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Dubin in 2015. Dr. Dubin's most frequent co-authors are Wilson T. Kwong, MD, Braj Bhushan Pandey, MD and Thomas John Savides, MD.

CMS Open Payments shows 161 general payments to Dr. Dubin from 22 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 93% of the total. Abbvie Inc. paid the most, $1,002.

Dmand AI lists 1 award for Dr. Dubin, most recently AOA Inductee 2011 in 2011.

Dr. Dubin graduated from George Washington University School of Medicine and Health Sciences in 2011. Dr. Dubin is a member of AOA.

Dr. Dubin is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.